Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

VersaCross Steerable Access Solution.

VersaCross™ Steerable Access Solution

Trusted transseptal technology with integrated steerable control

The 8.5 F VersaCross Steerable Access Solution eliminates the need for a fixed curve sheath and enables zero exchange access-to-delivery.

The VersaCross Steerable Access Solution is an integrated transseptal access and steerable sheath system designed to streamline left heart workflows by eliminating the need for a fixed sheath. It combines the 3-in-1 VersaCross RF Wire, a reinforced shapeable dilator, and a high-precision steerable sheath for controlled, zero exchange access-to-delivery of left heart therapy devices.

Why choose VersaCross Steerable Access Solution

Bidirectional steering using the VersaCross Steerable Sheath.

High-precision steering

The VersaCross Steerable Sheath provides smooth and responsive bidirectional steering for precise navigation and positioning.*

Gloved hand turning the dial of the VersaCross Steerable Sheath.

Intuitive handling

Responsive TruGlide™ handling and intuitive tactile feedback enhance operator awareness of sheath deflection, supporting confident manipulation and articulation.*

VersaCross Steerable Sheath with an ablation catheter in a curved position.

Reliable curve retention

Engineered with a self-locking dial, the strong and durable VersaCross Steerable Sheath maintains curve integrity to support stable positioning.*

VersaCross Steerable Access Solution assembly with pigtail RF wire.

Sophisticated 3-in-1 RF wire

The 3-in-1 VersaCross RF Wire eliminates exchanges by serving as a starter wire, RF puncture device, and exchange guidewire. Its optimized electrode design enables precise, site-specific crossing, allowing operators to optimize transseptal location even in challenging anatomies.*,1,2

Gloved hand shaping the VersaCross dilator and sheath assembly.

Reinforced transseptal dilator

Reinforced with TRUform™ shapeable technology, the VersaCross Transseptal Dilator facilitates a familiar handling experience to a needle-based transseptal system and retains your curve to optimize transseptal assembly positioning.*

RFP-100A RF Puncture Generator.

Dedicated RF puncture generator

The RFP-100A™ RF Puncture Generator was designed to create small, targeted transseptal punctures via the delivery of proprietary RF energy waveforms. When used with the VersaCross RF Wire, this system has been shown to facilitate more consistent transseptal puncture with fewer and lower energy applications compared to electrified needles or guidewires.*,3,4

Eliminate the need for a fixed curve sheath

Visual comparison of three transseptal access workflows: VersaCross Steerable Access Solution (6 steps), VersaCross Access Solution (8 steps), and a traditional needle-based workflow (12 steps).

The VersaCross Steerable Access Solution eliminates the need for a fixed curve sheath, enabling zero exchange access-to-delivery of left heart therapies with a single solution from start to finish. Compared to a traditional workflow where a fixed curve sheath is followed by an exchange for a steerable sheath, it streamlines transseptal access and supports a more efficient procedural approach.

Publication highlights

October 2023, Berggren et al., published in Indian Pacing and Electrophysiology Journal

In atrial fibrillation (AF) patients, utilization of the VersaCross Steerable Sheath and pigtail RF wire for transseptal puncture and RF ablation reduced the number of device exchanges, leading to improved procedural efficiency compared to the standard workflow (puncture using an NRG™ RF needle and 8.5F sheath, followed by exchange for an Agilis™ NXT steerable sheath).


November 2022, Dewland et al., published in JACC: Clinical Electrophysiology

RF wire-based transseptal workflow resulted in a faster time to transseptal puncture, with fewer exchanges for RF ablation, compared to an RF needle-based workflow.


December 2021, Hiner et al., published in Journal of Innovations in Cardiac Rhythm Management

In AF patients, utilization of the VersaCross Steerable Sheath and pigtail RF wire for transseptal puncture and RF ablation reduced the number of device exchanges, leading to improved procedural efficiency compared to the standard workflow (puncture using an NRG RF needle and 8.5F sheath, followed by exchange for an Agilis NXT steerable sheath).


White papers

September 2018

The VersaCross Steerable Sheath demonstrated more responsive steering and smoother dial rotation, with a more linear force-rotation profile and two times more consistency in force-to-turn the dial.


November 2017

The VersaCross Steerable Sheath demonstrated a significantly smoother sheath-to-dilator transition and a significantly lower force to cross.


November 2017

The VersaCross Steerable Sheath demonstrated greater retention of curve range-of-motion and durability, remaining intact after 300 articulation cycles.

Ordering information

1. Choose your VersaCross RF Wire

J-tip, pigtail

VersaCross RF Wire in j-tip and pigtail configurations.
VersaCross RF Wire
RF wire length: 180 cm, 230 cm (pigtail)
Wire diameter: 0.035 in (0.89 mm)
Curve diameter: 9 mm (j-tip), 24 mm (pigtail)
2. Choose your sheath to complete your solution

S,M,L

VersaCross Steerable Sheath in small, medium, and large curve configurations.
VersaCross Steerable Sheath
Sheath curves: Small (S, 17mm), Medium (M, 22 mm), Large (L, 50 mm)
Bidirectional angles: 90° CCW, 180° CW

* Bench testing or pre-clinical study results may not necessarily be indicative of clinical performance. The testing was performed by or on behalf of Boston Scientific. Data on file.

† Baylis Medical Company Radiofrequency Puncture Generator RFP-100A™. Baylis Medical Company is a wholly owned subsidiary of Boston Scientific Corporation.

‡ Based on bench testing conducted using SureFlex Steerable Guiding Sheath, which has identical steering mechanisms to VersaCross Steerable Sheath. Bench testing or pre-clinical study results may not necessarily be indicative of clinical performance. The testing was performed by or on behalf of Boston Scientific. Data on file.

All trademarks are the property of their respective owners.

References

  1. Doshi SN, Savvoulidis P, Mechery A, et al. VersaCross Transseptal System for Mitral Transcatheter Edge-To-Edge Repair with the PASCAL Repair Platform. Struct Heart. 2023;In Press.
  2. Berggren K, Lampert T, Janardhan AH. Improved left atrial catheterization efficiency and consistency using a novel steerable transseptal puncture sheath. Indian Pacing Electrophysiol J. 2023;S0972-6292(23)00101-8. doi:10.1016/j.ipej.2023.10.001
  3. Knight BP, Wasserlauf J, Al-Dujaili S, Al-Ahmad A. Comparison of transseptal puncture using a dedicated RF wire versus a mechanical needle with and without electrification in an animal model. J Cardiovasc Electrophysiol. 2023. doi:10.1111/jce.16111
  4. Wasserlauf J, Knight BP. Comparing the safety and effectiveness of dedicated radiofrequency transseptal wires to electrified metal guidewires. J Cardiovasc Electrophysiol. 2022;33(3):371–379. doi:10.1111/jce.15341